Q-VD-OPh
1135695-98-5
99%
Yes
2026-11-25
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Details
-
Seller Information
-
Description
ProductName Q-VD-OPh Cat No CEI-0421 Description A synthetic peptide that is potent, cell permeable, nontoxic and irreversibly inhibits caspase activity to blocks apoptosis. The new generation of caspase inhibitor is more stable in aqueous environment and exhibits several folds higher activity than the corresponding FMK caspase inhibitors. Q-VD-OPH is the inhibitor of choice for both in vitro and in vivo studies. Alias Q-Val-Asp-OPh Appearance Off-white solid Product Overview A pan-caspase inhibitor CAS No 1135695-98-5 Molecular Weight 381.37 Purity >99% Storage -20 centigrade Synonyms Q-Val-Asp-OPh Targets caspase Molecular Formula C₂₆H₂₅F₂N₃O₆ Solubility DMSO (200 mg/ml) or EtOH (100 mg/ml) Shipping Conditions RT Amino Acid Sequence Quilyl-Val-Asp-OPHh category Specialty Chemicals(c26) cas_num 1135695-98-5 Basic Info-
Product Name:
Q-VD-OPhhydrate
Other Name:Q-VD-OPh hydrate;(3S)-5-(2,6-Difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxo-pentanoic acid;(3S)-5-(2,6-Difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxo-pentanoic acid hydrate;Quinoline-Val-Asp-Difluorophenoxymethylketone);CS-2734;Q-VD-OPh (QVD-OPH;QVD-OPH;QUINOLINE-VAL-ASP-DIFLUOROPHENOXYMETHYLKETONE;Pentanoic acid, 5-(2,6-difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxo-, (3S)-
CAS No.:1135695-98-5
Molecular Formula:C26H25F2N3O6
InChIKeys:OOBJCYKITXPCNS-REWPJTCUSA-N
Molecular Weight:513.49
Exact Mass:513.17114185
DSSTox ID:DTXSID90647322
Categories:
Characteristics-
Density:
1.346±0.06 g/cm3
Boiling Point:808.9±65.0 °C(Predicted)
PKA:3.92±0.19
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Linagliptin
/ 98%
-
-
-
-
Hirudin
/ 0.98%
-
-
-
-
Lipoprotein Lipase
/ 95%
-
-
-
-
MLS-573151
/ 98%
-